BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 31696625)

  • 1. Myocardial dysfunction in long-term breast cancer survivors treated at ages 40-50 years.
    Jacobse JN; Steggink LC; Sonke GS; Schaapveld M; Hummel YM; Steenbruggen TG; Lefrandt JD; Nuver J; Crijns APG; Aleman BMP; van der Meer P; Gietema JA; van Leeuwen FE
    Eur J Heart Fail; 2020 Feb; 22(2):338-346. PubMed ID: 31696625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved Cardiomyopathy Risk Prediction Using Global Longitudinal Strain and N-Terminal-Pro-B-Type Natriuretic Peptide in Survivors of Childhood Cancer Exposed to Cardiotoxic Therapy.
    Ehrhardt MJ; Liu Q; Mulrooney DA; Rhea IB; Dixon SB; Lucas JT; Sapkota Y; Shelton K; Ness KK; Srivastava DK; McDonald A; Robison LL; Hudson MM; Yasui Y; Armstrong GT
    J Clin Oncol; 2024 Apr; 42(11):1265-1277. PubMed ID: 38207238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global longitudinal strain at 3 months after therapy can predict late cardiotoxicity in breast cancer.
    Liu Z; Liu M; Zhong X; Qin Y; Liang T; Luo T; Yan X; Tang Z; Wang X; Liang S; Li Q; Ruan X; He W; Huang H
    Cancer Med; 2023 Jun; 12(12):13374-13387. PubMed ID: 37183826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global left ventricular longitudinal strain is closely associated with increased neurohormonal activation after acute myocardial infarction in patients with both reduced and preserved ejection fraction: a two-dimensional speckle tracking study.
    Ersbøll M; Valeur N; Mogensen UM; Andersen M; Greibe R; Møller JE; Hassager C; Søgaard P; Køber L
    Eur J Heart Fail; 2012 Oct; 14(10):1121-9. PubMed ID: 22753861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Impact of Global Longitudinal Strain and NT-proBNP on Early Development of Cardiotoxicity in Breast Cancer Patients Treated with Anthracycline-Based Chemotherapy.
    Muckiene G; Vaitiekus D; Zaliaduonyte D; Zabiela V; Verseckaite-Costa R; Vaiciuliene D; Juozaityte E; Jurkevicius R
    Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241185
    [No Abstract]   [Full Text] [Related]  

  • 6. Changes in Cardiovascular Biomarkers With Breast Cancer Therapy and Associations With Cardiac Dysfunction.
    Demissei BG; Hubbard RA; Zhang L; Smith AM; Sheline K; McDonald C; Narayan V; Domchek SM; DeMichele A; Shah P; Clark AS; Fox K; Matro J; Bradbury AR; Knollman H; Getz KD; Armenian SH; Januzzi JL; Tang WHW; Liu P; Ky B
    J Am Heart Assoc; 2020 Jan; 9(2):e014708. PubMed ID: 31959034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of N-terminal pro-brain natriuretic peptide to assess left ventricular function after adjuvant doxorubicin therapy in early breast cancer patients: a prospective series.
    Cil T; Kaplan AM; Altintas A; Akin AM; Alan S; Isikdogan A
    Clin Drug Investig; 2009; 29(2):131-7. PubMed ID: 19133708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac function in BRCA1/2 mutation carriers with history of breast cancer treated with anthracyclines.
    Barac A; Lynce F; Smith KL; Mete M; Shara NM; Asch FM; Nardacci MP; Wray L; Herbolsheimer P; Nunes RA; Swain SM; Warren R; Peshkin BN; Isaacs C
    Breast Cancer Res Treat; 2016 Jan; 155(2):285-93. PubMed ID: 26749359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of exercise training on cardiotoxicity and cardiac health outcomes in women with breast cancer anthracycline chemotherapy: a study protocol for a randomized controlled trial.
    Antunes P; Esteves D; Nunes C; Sampaio F; Ascensão A; Vilela E; Teixeira M; Amarelo AL; Joaquim A
    Trials; 2019 Jul; 20(1):433. PubMed ID: 31307527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of global longitudinal strain and plasma natriuretic peptide in patients with asymptomatic left ventricular dysfunction.
    Ulziisaikhan G; Khurelbaatar MU; Khorloo C; Sodovsuren N; Khasag A; Unurjargal T
    Kardiologiia; 2021 Oct; 61(10):53-60. PubMed ID: 34763639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Echocardiographic parameters of left ventricular size and function as predictors of symptomatic heart failure in patients with a left ventricular ejection fraction of 50-59% treated with anthracyclines.
    Mousavi N; Tan TC; Ali M; Halpern EF; Wang L; Scherrer-Crosbie M
    Eur Heart J Cardiovasc Imaging; 2015 Sep; 16(9):977-84. PubMed ID: 25925220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular systolic function in HER2/neu negative breast cancer patients treated with anthracycline chemotherapy: a comparative analysis of left ventricular ejection fraction and myocardial strain imaging over 12 months.
    Stoodley PW; Richards DA; Boyd A; Hui R; Harnett PR; Meikle SR; Byth K; Stuart K; Clarke JL; Thomas L
    Eur J Cancer; 2013 Nov; 49(16):3396-403. PubMed ID: 23937961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome of cardiac function in a population-based cohort of breast cancer survivors: A cross-sectional study.
    Boerman LM; Maass SWMC; van der Meer P; Gietema JA; Maduro JH; Hummel YM; Berger MY; de Bock GH; Berendsen AJ
    Eur J Cancer; 2017 Aug; 81():56-65. PubMed ID: 28601706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial 2D strain echocardiography and cardiac biomarkers in children during and shortly after anthracycline therapy for acute lymphoblastic leukaemia (ALL): a prospective study.
    Mavinkurve-Groothuis AM; Marcus KA; Pourier M; Loonen J; Feuth T; Hoogerbrugge PM; de Korte CL; Kapusta L
    Eur Heart J Cardiovasc Imaging; 2013 Jun; 14(6):562-9. PubMed ID: 23109647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormalities in 3-Dimensional Left Ventricular Mechanics With Anthracycline Chemotherapy Are Associated With Systolic and Diastolic Dysfunction.
    Zhang KW; Finkelman BS; Gulati G; Narayan HK; Upshaw J; Narayan V; Plappert T; Englefield V; Smith AM; Zhang C; Hundley WG; Ky B
    JACC Cardiovasc Imaging; 2018 Aug; 11(8):1059-1068. PubMed ID: 29550306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of myocardial performance index and biochemical markers for early detection of anthracycline-induced cardiotoxicity in adults.
    Dodos F; Halbsguth T; Erdmann E; Hoppe UC
    Clin Res Cardiol; 2008 May; 97(5):318-26. PubMed ID: 18193371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ivabradine for the Prevention of Anthracycline-Induced Cardiotoxicity in Female Patients with Primarily Breast Cancer: A Prospective, Randomized, Open-Label Clinical Trial.
    Čiburienė E; Aidietienė S; Ščerbickaitė G; Sadauskienė E; Sudavičienė D; Baltruškevičienė E; Brasiūnienė B; Drobnienė M; Čelutkienė J
    Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138243
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiotoxicity of anthracycline (ANT) treatment in children with malignant tumors.
    Hu H; Zhang W; Huang D; Yang Q; Li J; Gao Y
    Pediatr Hematol Oncol; 2018 Mar; 35(2):111-120. PubMed ID: 29648903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of Global Longitudinal Strain by Echocardiography to Detect Left Ventricular Dysfunction in Long-Term Adult Survivors of Childhood Lymphoma and Acute Lymphoblastic Leukemia.
    Christiansen JR; Massey R; Dalen H; Kanellopoulos A; Hamre H; Fosså SD; Ruud E; Kiserud CE; Aakhus S
    Am J Cardiol; 2016 Aug; 118(3):446-52. PubMed ID: 27296561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-Dimensional Speckle Tracking Echocardiography Detects Subclinical Left Ventricular Systolic Dysfunction among Adult Survivors of Childhood, Adolescent, and Young Adult Cancer.
    Yu AF; Raikhelkar J; Zabor EC; Tonorezos ES; Moskowitz CS; Adsuar R; Mara E; Huie K; Oeffinger KC; Steingart RM; Liu JE
    Biomed Res Int; 2016; 2016():9363951. PubMed ID: 26942202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.